Requests for withdrawal on December 31st (the year-end withdrawals) should be received by the Medicines Evaluation Board (MEB) on November 1st 2018 at the latest.
A request for withdrawal submitted on November 2nd or later might not be completed before the end of the year. Those requests will be completed within the usual time lines, and the date of withdrawal will be the day that the case is completed by the MEB. As a consequence the invoice for the annual fee might be sent to the marketing authorisation holder.
In case the request for withdrawal is received by the MEB before November 1st, but the product is not withdrawn on December 31st because of ongoing discussion on the necessity to keep the product available for the patients, the invoice for the annual fee will be sent. If the product is withdrawn in January of February after all, the marketing authorisation holder will receive a credit note.